The global cell therapy packaging market, valued at USD 404 million in 2025, is projected to reach USD 456 million in 2026 and USD 1,225 million by 2035, with a 11.6% CAGR during the forecast period 2026 to 2035. According to our projections, Asia-Pacific captures the major share (41%) in cell therapy packaging market and this trend is unlikely to change in the future. It is further worth highlighting that the cell therapy packaging in Europe is expected to grow at a relatively healthy CAGR (...

The global cell and gene therapy manufacturing market size, valued at USD 11.9 billion in 2024, is projected to reach USD 15.1 billion in 2025 and USD 160.0 billion by 2035, representing a CAGR of 26.64% during the forecast period. According to our projection, North America has the highest share (45%) of the market and the trend of dominance is likely to remain unchanged during the forecast period. North American region is currently dominating the industry with the highest share of 45%. . Accord...

The global viral vector manufacturing market, valued at USD 704 million in 2024, is estimated to reach USD 799 million in 2025 and USD 2,315 million by 2035, representing a CAGR of 11.23% during the forecast period. Over the past few years, these vectors have emerged as the key pre-requisites for cell and gene therapy manufacturing. It is worth mentioning that, till January 2023, over 25 viral vector based gene therapy products have been approved by different regulatory agencies, worldwide. In t...

The biologics fill finish manufacturing market, valued at USD 4.4 billion in 2025, is projected to reach USD 4.7 billion in 2026 and USD 8.4 billion by 2035, representing a CAGR of 6.71%, during the forecast period 2026 to 2035. Through our new market research study, we have identified the key market trends, competitive landscape, market forecast and opportunity for biologics fill finish service providers. The biologics fill finish manufacturing market growth over the next decade is expected to...

The continuous adoption of disposable mixer for bioreactor feed preparation offers a competitive advantage to market players to meet future demands and requirement of technological innovations. It is worth mentioning that the current focus will be on advanced sensor integration for real-time process optimization. In addition, numerous industrial players are emphasizing integrating artificial intelligence with single-use mixer for quality control and process optimization.For instance, in March 2...

These 3D cell culture models and organoids are used for studying drug safety and efficacy. In addition to clinical studies, the growing focus on stem cell therapy and regenerative medicine has further bolstered the demand for advanced 3D cell cultures and organoids.Considering the significances of advanced technology-based models, several industrial players are aiming to develop advanced organoid technologies and platforms for drug discovery and clinical studies. For instance, in July 2025, MD A...

The global genome editing market, valued at $4.25 billion in 2025, is projected to reach $5.29 billion in 2026 and $13.36 billion by 2035, representing a CAGR of 10.8% during the forecast period 2026 to 2035. more than 1,100 active clinical trials are evaluating gene therapies across various phases of clinical studies. According to the World Health Organization (WHO), 10 out of every 1,000 individuals are affected by genetic disorders, with over 70 million people worldwide living with such condi...

The global 3D cell culture market, valued at USD 2.16 billion in 2025, is projected to reach USD 2.61 billion in 2026 and USD 8.90 billion by 2035, with a 14.6% CAGR during the forecast period 2026 to 2035. Driven by the increasing requirement of animal model alternatives, the 3D cell culture market is anticipated to grow at a higher rate during the forecast period. According to our projection, use of 3d cell culture systems for cancer research is dominating the market and is likely to hold 41%...

The global T-cell therapy market, valued at USD 6.5 billion in 2025, is projected to grow to USD 8.1 billion in 2026 and USD 20.9 billion by 2035, representing a CAGR of 11.2% during the forecast period 2026 to 2035. According to NIH, in 2024, around 2 million people are estimated to be diagnosed with various types of cancer in the U.S. alone. The US FDA approved multiple T cell therapies targeting cancer (in reverse chronological order), such as Obecabtagene autoleucel / Aucatzyl (relapsed or r...

The global TIL therapy market, valued at USD 0.3 billion in 2025, is projected to reach USD 0.6 billion in 2026 and USD 4.2 billion by 2035, with a 23.4% CAGR during the forecast period 2026 to 2035. TILs are a heterogeneous population of mononuclear lymphocytes that comprise of T-cells, B-cells, Natural killer cell therapies and macrophages isolated from the tumor. Notably, over 75 TIL cell therapy are being evaluated across different stages of preclinical / clinical development, either as mono...

The TCR therapy market, valued at USD 442 million in 2025, is projected to reach USD 533 million in 2026 and USD 1,563 million by 2035, with a 12.7% CAGR during the forecast period 2026 to 2035, mainly driven by the need for targeted cancer treatment for solid tumors. Presently, more than 100 industry and non-industry players across the globe are evaluating the potential of over 190 T cell receptor based immunotherapies for the treatment of various oncological and non-oncological disorders. Furt...

The industrial players such as Merck, Thermo Fisher Scientific and STEMCELL Technologies are increasingly emphasizing adult stem cells specifically those collected from adipose tissues / bone marrow to repair tissue damage and development of stem cell therapies for targeting wide range of diseases. In April 2025, Abu Dhabi Biobank launched an affordable private cord blood banking which offers an affordable and accessible way to preserve their newborns stem cells.

The biopreservation market for media, valued at USD 1.9 billion in 2025, is projected to reach USD 2.3 billion in 2026 and USD 15.5 billion by 2035, with a 23.6% CAGR during the forecast period 2026 to 2035. At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Further, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it w...

The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period. The new research study consists of industry trends, detailed market analysis, clinical trial analysis, likely drug candidates and market impact analysis, along with the market forecast and opportunity analysis. Currently, there are more than 1,000 cell and gene therapies under development, most of which are being d...

The global biohacking market, valued at USD 23.63 billion in 2024, is projected to reach USD 28.73 billion in 2025 and USD 137.37 billion by 2035, representing a CAGR of 16.9% during the forecast period. As more market players continue to accelerate innovation in this field, we believe the global biohacking industry will continue to expand at a steady rate during the forecast period.

The global immuno-oncology drugs market, valued at USD 80.82 billion in 2024, is projected to reach USD 97.52 billion in 2025 and USD 442.26 billion by 2035, representing a CAGR of 16.3% during the forecast period. Driven by the ongoing initiatives and accelerated approval, we believe that immuno-oncology drugs market will continue to grow at a steady pace during the forecast period.

The global cell cytometry market size, valued at USD 1.99 billion in 2025, is projected to reach USD 2.18 billion in 2026 and USD 5.27 billion by 2035, representing a CAGR of 10.3% during the forecast period. Cell cytometry is an advanced analytical technique that helps in the analysis and characterization of cells. This technology has recently gained momentum across healthcare and pharmaceutical industry for the identification of biomarkers and evaluating the relationship between pharmacodynami...

The global hair transplant market size is valued at USD 8.01 billion in 2024 and is estimated to reach USD 15.65 billion by 2035, representing a CAGR of 6.28%, during the forecast period. It is important to highlight here that in March 2023, Venus Concept successfully launched the latest generation of ARTAS iX for hair transplantation, which is integrated with several technologies, such as machine learning, artificial intelligence and surgical robots. In addition to technological innovations, se...

The global orthopedic devices market size, valued at USD 60.56 billion in 2024, is projected to reach USD 63.51 billion in 2025 and USD 92.61 billion by 2035, representing a CAGR of 3.8% during the forecast period. Driven by the increasing adoption, several industrial players have shown active participation in this field to develop advanced orthopedic devices to meet unmet requirements of patients. However, the primary focus of industrial players will remain on technological innovations, wearabl...

The global cartilage repair market, valued at USD 1.57 billion in 2024, is projected to reach USD 1.77 billion in 2025 and USD 4.77 billion by 2035, representing a CAGR of 10.3% during the forecast period. According to our projection, currently, cell-based segment holds the highest share (63%) of the cartilage repair industry.